These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6581410)

  • 1. The management of primary open-angle glaucoma.
    Hadden OB
    N Z Med J; 1983 Dec; 96(746):1051. PubMed ID: 6581410
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of local hypotensive therapy on ocular hemodynamics in patients with primary open-angle glaucoma].
    Bakshinskiĭ PP
    Vestn Oftalmol; 1999; 115(1):8-10. PubMed ID: 10207311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
    Kałuzny JJ; Szaflik J; Czechowicz-Janicka K; Kałuzny J; Orzałkiewicz A; Zaleska-Zmijewska A; Krajewska M; Stewart JA; Leech JN; Stewart WC
    Klin Oczna; 2004; 106(1-2 Suppl):241-2. PubMed ID: 15510513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prepared association of metipranolol 0.1% + pilocarpine 2% and of timolol 0.5% + pilocarpine 2%. Comparison of clinical efficacy and topical tolerability in the treatment of patients affected by POAG tonometrically uncontrolled with beta-blocker alone (two-centre study).
    Boles Carenini B; Brogliatti B; Dorigo MT; Vadalà G; Protti R; Bellone A
    Acta Ophthalmol Scand Suppl; 1997; (224):54-5. PubMed ID: 9589740
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative evaluation of pilocarpine 1% and clonidine 0.125% versus timolol 0.5%.
    Sihota R; Agarwal HC; Rajashekar YL
    Indian J Ophthalmol; 1996 Jun; 44(2):87-9. PubMed ID: 8916595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glaucoma.
    Richards RD
    Am Fam Physician; 1987 Jan; 35(1):212-20. PubMed ID: 2879433
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary argon laser trabeculoplasty vs pilocarpine 2% in primary open angle glaucoma: two years follow-up study.
    Sharma A; Gupta A
    Indian J Ophthalmol; 1997 Jun; 45(2):109-13. PubMed ID: 9475029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marfan syndrome, lens subluxation, and open-angle glaucoma.
    Krupin T
    J Glaucoma; 1999 Dec; 8(6):396-9. PubMed ID: 10604300
    [No Abstract]   [Full Text] [Related]  

  • 10. Timolol-pilocarpine fixed-ratio combinations in the treatment of chronic open angle glaucoma.
    Moriarty AP; Dowd TC
    Arch Ophthalmol; 1993 Oct; 111(10):1313-4. PubMed ID: 8216000
    [No Abstract]   [Full Text] [Related]  

  • 11. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
    Sverrisson T; Gross R; Pearson J; Rusk C; Adamsons I
    J Glaucoma; 1999 Oct; 8(5):315-24. PubMed ID: 10529932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aceclidine in primary open angle chronic glaucoma already treated with pilocarpine: comparison between the 2 drugs].
    Agugini G; Stecchi G
    Ann Ottalmol Clin Ocul; 1968 Jan; 94(1):1-8. PubMed ID: 5745521
    [No Abstract]   [Full Text] [Related]  

  • 13. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
    Adamsons IA; Polis A; Ostrov CS; Boyle JE
    J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of timoptol in primary open-angle glaucoma patients over 60. Comments on 100 cases].
    Clergeau G; Pechereau A
    Bull Soc Ophtalmol Fr; 1981 Dec; 81(12):1195-9. PubMed ID: 7044586
    [No Abstract]   [Full Text] [Related]  

  • 15. [2 years' administration of timolol to patients with chronic open-angle glaucoma].
    Novakovic A; Vujosevic E; Alajbegovic R; Hodzic S
    Bull Soc Ophtalmol Fr; 1982 Mar; 82(3):311-2. PubMed ID: 7116526
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical management of glaucoma.
    Indian J Ophthalmol; 1983 Mar; 31(2):95-7. PubMed ID: 6662579
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proxodolol, a new domestic preparation for lowering intraocular pressure in glaucoma].
    Ermakova VN; Iuzhakov SD; Mashkovskiĭ MD; Kolomoĭtseva EM
    Vestn Oftalmol; 1995; 111(2):4-7. PubMed ID: 7645180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine.
    Robin AL
    Trans Am Ophthalmol Soc; 1996; 94():89-101; discussion 101-3. PubMed ID: 8981691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.